131 related articles for article (PubMed ID: 36375119)
1. BTG1 inactivation drives lymphomagenesis and promotes lymphoma dissemination through activation of BCAR1.
Delage L; Lambert M; Bardel É; Kundlacz C; Chartoire D; Conchon A; Peugnet AL; Gorka L; Auberger P; Jacquel A; Soussain C; Destaing O; Delecluse HJ; Delecluse S; Merabet S; Traverse-Glehen A; Salles G; Bachy E; Billaud M; Ghesquières H; Genestier L; Rouault JP; Sujobert P
Blood; 2023 Mar; 141(10):1209-1220. PubMed ID: 36375119
[TBL] [Abstract][Full Text] [Related]
2. Conformational transitions in BTG1 antiproliferative protein and their modulation by disease mutants.
Kots E; Mlynarczyk C; Melnick A; Khelashvili G
Biophys J; 2022 Oct; 121(19):3753-3764. PubMed ID: 35459639
[TBL] [Abstract][Full Text] [Related]
3. Identification of B-cell translocation gene 1-controlled gene networks in diffuse large B-cell lymphoma: A study based on bioinformatics analysis.
Yan W; Li SX; Gao H; Yang W
Oncol Lett; 2019 Mar; 17(3):2825-2835. PubMed ID: 30854058
[TBL] [Abstract][Full Text] [Related]
4. Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation.
Knies N; Alankus B; Weilemann A; Tzankov A; Brunner K; Ruff T; Kremer M; Keller UB; Lenz G; Ruland J
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7230-8. PubMed ID: 26668357
[TBL] [Abstract][Full Text] [Related]
5. Association of the breast cancer antiestrogen resistance protein 1 (BCAR1) and BCAR3 scaffolding proteins in cell signaling and antiestrogen resistance.
Wallez Y; Riedl SJ; Pasquale EB
J Biol Chem; 2014 Apr; 289(15):10431-10444. PubMed ID: 24584939
[TBL] [Abstract][Full Text] [Related]
6. Tamoxifen treatment promotes phosphorylation of the adhesion molecules, p130Cas/BCAR1, FAK and Src, via an adhesion-dependent pathway.
Cowell LN; Graham JD; Bouton AH; Clarke CL; O'Neill GM
Oncogene; 2006 Dec; 25(58):7597-607. PubMed ID: 16799644
[TBL] [Abstract][Full Text] [Related]
7. Tumor suppressor BTG1 promotes PRMT1-mediated ATF4 function in response to cellular stress.
Yuniati L; van der Meer LT; Tijchon E; van Ingen Schenau D; van Emst L; Levers M; Palit SA; Rodenbach C; Poelmans G; Hoogerbrugge PM; Shan J; Kilberg MS; Scheijen B; van Leeuwen FN
Oncotarget; 2016 Jan; 7(3):3128-43. PubMed ID: 26657730
[TBL] [Abstract][Full Text] [Related]
8. Dysregulated CXCR4 expression promotes lymphoma cell survival and independently predicts disease progression in germinal center B-cell-like diffuse large B-cell lymphoma.
Chen J; Xu-Monette ZY; Deng L; Shen Q; Manyam GC; Martinez-Lopez A; Zhang L; Montes-Moreno S; Visco C; Tzankov A; Yin L; Dybkaer K; Chiu A; Orazi A; Zu Y; Bhagat G; Richards KL; Hsi ED; Choi WW; van Krieken JH; Huh J; Ponzoni M; Ferreri AJ; Zhao X; Møller MB; Farnen JP; Winter JN; Piris MA; Pham L; Young KH
Oncotarget; 2015 Mar; 6(8):5597-614. PubMed ID: 25704881
[TBL] [Abstract][Full Text] [Related]
9. DUSP4 deficiency caused by promoter hypermethylation drives JNK signaling and tumor cell survival in diffuse large B cell lymphoma.
Schmid CA; Robinson MD; Scheifinger NA; Müller S; Cogliatti S; Tzankov A; Müller A
J Exp Med; 2015 May; 212(5):775-92. PubMed ID: 25847947
[TBL] [Abstract][Full Text] [Related]
10. Diffuse large B-cell lymphoma and red cell autoimmunity: clinical role and pathogenesis.
Coombes C; Horikawa K; Jain S; Jiang S; Lim JH; Saxena K; Shadbolt B; Smyth L; Tobin J; Talaulikar D
Pathology; 2023 Feb; 55(1):104-112. PubMed ID: 36420560
[TBL] [Abstract][Full Text] [Related]
11. B-cell-specific conditional expression of Myd88p.L252P leads to the development of diffuse large B-cell lymphoma in mice.
Knittel G; Liedgens P; Korovkina D; Seeger JM; Al-Baldawi Y; Al-Maarri M; Fritz C; Vlantis K; Bezhanova S; Scheel AH; Wolz OO; Reimann M; Möller P; López C; Schlesner M; Lohneis P; Weber AN; Trümper L; ; Staudt LM; Ortmann M; Pasparakis M; Siebert R; Schmitt CA; Klatt AR; Wunderlich FT; Schäfer SC; Persigehl T; Montesinos-Rongen M; Odenthal M; Büttner R; Frenzel LP; Kashkar H; Reinhardt HC
Blood; 2016 Jun; 127(22):2732-41. PubMed ID: 27048211
[TBL] [Abstract][Full Text] [Related]
12. MYD88, CARD11, and CD79B Oncogenic Mutations are Rare Events in the Indian Cohort of De Novo Nodal Diffuse Large B-Cell Lymphoma.
Aggarwal V; Das A; Bal A; Srinivasan R; Das R; Prakash G; Malhotra P; Varma S
Appl Immunohistochem Mol Morphol; 2019 Apr; 27(4):311-318. PubMed ID: 29734251
[TBL] [Abstract][Full Text] [Related]
13. Tumor suppressors BTG1 and IKZF1 cooperate during mouse leukemia development and increase relapse risk in B-cell precursor acute lymphoblastic leukemia patients.
Scheijen B; Boer JM; Marke R; Tijchon E; van Ingen Schenau D; Waanders E; van Emst L; van der Meer LT; Pieters R; Escherich G; Horstmann MA; Sonneveld E; Venn N; Sutton R; Dalla-Pozza L; Kuiper RP; Hoogerbrugge PM; den Boer ML; van Leeuwen FN
Haematologica; 2017 Mar; 102(3):541-551. PubMed ID: 27979924
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic Mutations and Tumor Microenvironment Alterations of Older Patients With Diffuse Large B-Cell Lymphoma.
Zhu Y; Fu D; Shi Q; Shi Z; Dong L; Yi H; Liu Z; Feng Y; Liu Q; Fang H; Cheng S; Wang L; Tian Q; Xu P; Zhao W
Front Immunol; 2022; 13():842439. PubMed ID: 35401516
[TBL] [Abstract][Full Text] [Related]
15. Diversity of clinical implication of B-cell translocation gene 1 expression by histopathologic and anatomic subtypes of gastric cancer.
Kanda M; Oya H; Nomoto S; Takami H; Shimizu D; Hashimoto R; Sueoka S; Kobayashi D; Tanaka C; Yamada S; Fujii T; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Dig Dis Sci; 2015 May; 60(5):1256-64. PubMed ID: 25487193
[TBL] [Abstract][Full Text] [Related]
16. A novel function of B-cell translocation gene 1 (BTG1) in the regulation of hepatic insulin sensitivity in mice via c-Jun.
Xiao F; Deng J; Yu J; Guo Y; Chen S; Guo F
FASEB J; 2016 Jan; 30(1):348-59. PubMed ID: 26396236
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of CREBBP expands the germinal center B cell compartment, down-regulates MHCII expression and promotes DLBCL growth.
Hashwah H; Schmid CA; Kasser S; Bertram K; Stelling A; Manz MG; Müller A
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9701-9706. PubMed ID: 28831000
[TBL] [Abstract][Full Text] [Related]
18. Regulation of p130(Cas)/BCAR1 expression in tamoxifen-sensitive and tamoxifen-resistant breast cancer cells by EGR1 and NAB2.
Kumbrink J; Kirsch KH
Neoplasia; 2012 Feb; 14(2):108-20. PubMed ID: 22431919
[TBL] [Abstract][Full Text] [Related]
19. Tumor suppressors BTG1 and BTG2: Beyond growth control.
Yuniati L; Scheijen B; van der Meer LT; van Leeuwen FN
J Cell Physiol; 2019 May; 234(5):5379-5389. PubMed ID: 30350856
[TBL] [Abstract][Full Text] [Related]
20. Mutant TP53 interacts with BCAR1 to contribute to cancer cell invasion.
Guo AK; Itahana Y; Seshachalam VP; Chow HY; Ghosh S; Itahana K
Br J Cancer; 2021 Jan; 124(1):299-312. PubMed ID: 33144694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
